BlackRock Capital Allocation Trust (BCAT) Stock Competitors & Peer Comparison
See (BCAT) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BCAT | $16.12 | +0.75% | 1.7B | 7.60 | $2.12 | +19.81% |
| VSMPX | $339.34 | +0.88% | 2.3T | 26.46 | $12.82 | N/A |
| VITSX | $180.90 | +0.88% | 2.3T | -1507.50 | -$0.12 | N/A |
| VTSAX | $180.87 | +0.88% | 2.3T | 26.46 | $6.83 | +1.05% |
| PMFLX | $10.17 | +0.10% | 2T | N/A | N/A | N/A |
| VFIAX | $696.22 | +0.82% | 1.7T | 26.96 | $25.82 | N/A |
| VOO | $693.86 | +0.46% | 1.7T | 27.08 | $25.62 | +1.06% |
| VFFSX | $369.15 | +0.82% | 1.7T | 26.96 | $13.69 | N/A |
| VFINX | $696.35 | +0.82% | 1.7T | 26.97 | $25.82 | N/A |
| FXAIX | $262.83 | +0.82% | 827.5B | N/A | N/A | N/A |
Stock Comparison
BCAT vs VSMPX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VSMPX has a market cap of 2.3T. Regarding current trading prices, BCAT is priced at $16.12, while VSMPX trades at $339.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VSMPX's P/E ratio is 26.46. In terms of profitability, BCAT's ROE is +0.13%, compared to VSMPX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VSMPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VSMPX's competition here
BCAT vs VITSX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VITSX has a market cap of 2.3T. Regarding current trading prices, BCAT is priced at $16.12, while VITSX trades at $180.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VITSX's P/E ratio is -1507.50. In terms of profitability, BCAT's ROE is +0.13%, compared to VITSX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VITSX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VITSX's competition here
BCAT vs VTSAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VTSAX has a market cap of 2.3T. Regarding current trading prices, BCAT is priced at $16.12, while VTSAX trades at $180.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VTSAX's P/E ratio is 26.46. In terms of profitability, BCAT's ROE is +0.13%, compared to VTSAX's ROE of +0.08%. Regarding short-term risk, BCAT is more volatile compared to VTSAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTSAX's competition here
BCAT vs PMFLX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, PMFLX has a market cap of 2T. Regarding current trading prices, BCAT is priced at $16.12, while PMFLX trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas PMFLX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to PMFLX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to PMFLX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check PMFLX's competition here
BCAT vs VFIAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VFIAX has a market cap of 1.7T. Regarding current trading prices, BCAT is priced at $16.12, while VFIAX trades at $696.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VFIAX's P/E ratio is 26.96. In terms of profitability, BCAT's ROE is +0.13%, compared to VFIAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VFIAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VFIAX's competition here
BCAT vs VOO Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VOO has a market cap of 1.7T. Regarding current trading prices, BCAT is priced at $16.12, while VOO trades at $693.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VOO's P/E ratio is 27.08. In terms of profitability, BCAT's ROE is +0.13%, compared to VOO's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VOO. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VOO's competition here
BCAT vs VFFSX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VFFSX has a market cap of 1.7T. Regarding current trading prices, BCAT is priced at $16.12, while VFFSX trades at $369.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VFFSX's P/E ratio is 26.96. In terms of profitability, BCAT's ROE is +0.13%, compared to VFFSX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VFFSX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VFFSX's competition here
BCAT vs VFINX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VFINX has a market cap of 1.7T. Regarding current trading prices, BCAT is priced at $16.12, while VFINX trades at $696.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VFINX's P/E ratio is 26.97. In terms of profitability, BCAT's ROE is +0.13%, compared to VFINX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VFINX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VFINX's competition here
BCAT vs FXAIX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FXAIX has a market cap of 827.5B. Regarding current trading prices, BCAT is priced at $16.12, while FXAIX trades at $262.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FXAIX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FXAIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FXAIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FXAIX's competition here
BCAT vs SPY Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, SPY has a market cap of 791.9B. Regarding current trading prices, BCAT is priced at $16.12, while SPY trades at $754.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas SPY's P/E ratio is 417.07. In terms of profitability, BCAT's ROE is +0.13%, compared to SPY's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to SPY. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check SPY's competition here
BCAT vs VTIAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VTIAX has a market cap of 654.5B. Regarding current trading prices, BCAT is priced at $16.12, while VTIAX trades at $45.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VTIAX's P/E ratio is 17.78. In terms of profitability, BCAT's ROE is +0.13%, compared to VTIAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VTIAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTIAX's competition here
BCAT vs VTPSX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VTPSX has a market cap of 651.7B. Regarding current trading prices, BCAT is priced at $16.12, while VTPSX trades at $182.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VTPSX's P/E ratio is 17.78. In terms of profitability, BCAT's ROE is +0.13%, compared to VTPSX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VTPSX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTPSX's competition here
BCAT vs VTSNX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VTSNX has a market cap of 642.7B. Regarding current trading prices, BCAT is priced at $16.12, while VTSNX trades at $182.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VTSNX's P/E ratio is 17.78. In terms of profitability, BCAT's ROE is +0.13%, compared to VTSNX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VTSNX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTSNX's competition here
BCAT vs QQQ Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, QQQ has a market cap of 499.7B. Regarding current trading prices, BCAT is priced at $16.12, while QQQ trades at $725.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas QQQ's P/E ratio is 33.31. In terms of profitability, BCAT's ROE is +0.13%, compared to QQQ's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to QQQ. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check QQQ's competition here
BCAT vs BMOP Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, BMOP has a market cap of 440.7B. Regarding current trading prices, BCAT is priced at $16.12, while BMOP trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas BMOP's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to BMOP's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to BMOP. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check BMOP's competition here
BCAT vs VUG Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VUG has a market cap of 402.1B. Regarding current trading prices, BCAT is priced at $16.12, while VUG trades at $87.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VUG's P/E ratio is 33.73. In terms of profitability, BCAT's ROE is +0.13%, compared to VUG's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VUG. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VUG's competition here
BCAT vs VBMFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VBMFX has a market cap of 396.6B. Regarding current trading prices, BCAT is priced at $16.12, while VBMFX trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VBMFX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to VBMFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VBMFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VBMFX's competition here
BCAT vs VIGAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VIGAX has a market cap of 395.3B. Regarding current trading prices, BCAT is priced at $16.12, while VIGAX trades at $268.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VIGAX's P/E ratio is 33.58. In terms of profitability, BCAT's ROE is +0.13%, compared to VIGAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VIGAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VIGAX's competition here
BCAT vs VIGIX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VIGIX has a market cap of 395.3B. Regarding current trading prices, BCAT is priced at $16.12, while VIGIX trades at $268.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VIGIX's P/E ratio is 33.58. In terms of profitability, BCAT's ROE is +0.13%, compared to VIGIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VIGIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VIGIX's competition here
BCAT vs CGFAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, CGFAX has a market cap of 364.8B. Regarding current trading prices, BCAT is priced at $16.12, while CGFAX trades at $85.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas CGFAX's P/E ratio is 33.23. In terms of profitability, BCAT's ROE is +0.13%, compared to CGFAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CGFAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CGFAX's competition here
BCAT vs GFFFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, GFFFX has a market cap of 363.3B. Regarding current trading prices, BCAT is priced at $16.12, while GFFFX trades at $87.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas GFFFX's P/E ratio is 32.44. In terms of profitability, BCAT's ROE is +0.13%, compared to GFFFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to GFFFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check GFFFX's competition here
BCAT vs AGTHX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AGTHX has a market cap of 363.3B. Regarding current trading prices, BCAT is priced at $16.12, while AGTHX trades at $87.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AGTHX's P/E ratio is 33.23. In terms of profitability, BCAT's ROE is +0.13%, compared to AGTHX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AGTHX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AGTHX's competition here
BCAT vs GFAFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, GFAFX has a market cap of 363.3B. Regarding current trading prices, BCAT is priced at $16.12, while GFAFX trades at $86.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas GFAFX's P/E ratio is 33.22. In terms of profitability, BCAT's ROE is +0.13%, compared to GFAFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to GFAFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check GFAFX's competition here
BCAT vs GAFFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, GAFFX has a market cap of 360.6B. Regarding current trading prices, BCAT is priced at $16.12, while GAFFX trades at $87.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas GAFFX's P/E ratio is 33.26. In terms of profitability, BCAT's ROE is +0.13%, compared to GAFFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to GAFFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check GAFFX's competition here
BCAT vs RGAGX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RGAGX has a market cap of 360.6B. Regarding current trading prices, BCAT is priced at $16.12, while RGAGX trades at $87.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RGAGX's P/E ratio is 33.26. In terms of profitability, BCAT's ROE is +0.13%, compared to RGAGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RGAGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RGAGX's competition here
BCAT vs VIIIX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VIIIX has a market cap of 352.6B. Regarding current trading prices, BCAT is priced at $16.12, while VIIIX trades at $603.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VIIIX's P/E ratio is 26.96. In terms of profitability, BCAT's ROE is +0.13%, compared to VIIIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VIIIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VIIIX's competition here
BCAT vs VINIX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VINIX has a market cap of 351.6B. Regarding current trading prices, BCAT is priced at $16.12, while VINIX trades at $603.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VINIX's P/E ratio is 26.96. In terms of profitability, BCAT's ROE is +0.13%, compared to VINIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VINIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VINIX's competition here
BCAT vs VDIPX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VDIPX has a market cap of 317.8B. Regarding current trading prices, BCAT is priced at $16.12, while VDIPX trades at $35.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VDIPX's P/E ratio is 18.21. In terms of profitability, BCAT's ROE is +0.13%, compared to VDIPX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VDIPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VDIPX's competition here
BCAT vs VEA Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VEA has a market cap of 317.8B. Regarding current trading prices, BCAT is priced at $16.12, while VEA trades at $70.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VEA's P/E ratio is 18.31. In terms of profitability, BCAT's ROE is +0.13%, compared to VEA's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VEA. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VEA's competition here
BCAT vs VTMGX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VTMGX has a market cap of 312.2B. Regarding current trading prices, BCAT is priced at $16.12, while VTMGX trades at $22.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VTMGX's P/E ratio is 18.21. In terms of profitability, BCAT's ROE is +0.13%, compared to VTMGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VTMGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTMGX's competition here
BCAT vs VTMNX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VTMNX has a market cap of 312B. Regarding current trading prices, BCAT is priced at $16.12, while VTMNX trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VTMNX's P/E ratio is 18.21. In terms of profitability, BCAT's ROE is +0.13%, compared to VTMNX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VTMNX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTMNX's competition here
BCAT vs RLBGX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RLBGX has a market cap of 288.9B. Regarding current trading prices, BCAT is priced at $16.12, while RLBGX trades at $40.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RLBGX's P/E ratio is 26.54. In terms of profitability, BCAT's ROE is +0.13%, compared to RLBGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RLBGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RLBGX's competition here
BCAT vs BALFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, BALFX has a market cap of 288.3B. Regarding current trading prices, BCAT is priced at $16.12, while BALFX trades at $40.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas BALFX's P/E ratio is 26.55. In terms of profitability, BCAT's ROE is +0.13%, compared to BALFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to BALFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check BALFX's competition here
BCAT vs ABALX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, ABALX has a market cap of 288.3B. Regarding current trading prices, BCAT is priced at $16.12, while ABALX trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas ABALX's P/E ratio is 26.54. In terms of profitability, BCAT's ROE is +0.13%, compared to ABALX's ROE of +0.13%. Regarding short-term risk, BCAT is more volatile compared to ABALX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check ABALX's competition here
BCAT vs AFMBX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AFMBX has a market cap of 287.6B. Regarding current trading prices, BCAT is priced at $16.12, while AFMBX trades at $40.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AFMBX's P/E ratio is 26.54. In terms of profitability, BCAT's ROE is +0.13%, compared to AFMBX's ROE of +0.13%. Regarding short-term risk, BCAT is more volatile compared to AFMBX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AFMBX's competition here
BCAT vs CLBAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, CLBAX has a market cap of 287.6B. Regarding current trading prices, BCAT is priced at $16.12, while CLBAX trades at $40.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas CLBAX's P/E ratio is 26.54. In terms of profitability, BCAT's ROE is +0.13%, compared to CLBAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CLBAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CLBAX's competition here
BCAT vs AMBFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AMBFX has a market cap of 287.6B. Regarding current trading prices, BCAT is priced at $16.12, while AMBFX trades at $40.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AMBFX's P/E ratio is 26.54. In terms of profitability, BCAT's ROE is +0.13%, compared to AMBFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AMBFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AMBFX's competition here
BCAT vs RGABX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RGABX has a market cap of 270.2B. Regarding current trading prices, BCAT is priced at $16.12, while RGABX trades at $76.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RGABX's P/E ratio is 32.27. In terms of profitability, BCAT's ROE is +0.13%, compared to RGABX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RGABX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RGABX's competition here
BCAT vs RGAAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RGAAX has a market cap of 265.2B. Regarding current trading prices, BCAT is priced at $16.12, while RGAAX trades at $74.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RGAAX's P/E ratio is 32.27. In terms of profitability, BCAT's ROE is +0.13%, compared to RGAAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RGAAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RGAAX's competition here
BCAT vs FCTDX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FCTDX has a market cap of 259.1B. Regarding current trading prices, BCAT is priced at $16.12, while FCTDX trades at $22.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FCTDX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FCTDX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FCTDX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FCTDX's competition here
BCAT vs GFACX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, GFACX has a market cap of 258.2B. Regarding current trading prices, BCAT is priced at $16.12, while GFACX trades at $72.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas GFACX's P/E ratio is 33.16. In terms of profitability, BCAT's ROE is +0.13%, compared to GFACX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to GFACX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check GFACX's competition here
BCAT vs VVIAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VVIAX has a market cap of 253.3B. Regarding current trading prices, BCAT is priced at $16.12, while VVIAX trades at $85.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VVIAX's P/E ratio is 21.62. In terms of profitability, BCAT's ROE is +0.13%, compared to VVIAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VVIAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VVIAX's competition here
BCAT vs SWVXX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, SWVXX has a market cap of 245.3B. Regarding current trading prices, BCAT is priced at $16.12, while SWVXX trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas SWVXX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to SWVXX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to SWVXX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check SWVXX's competition here
BCAT vs VTV Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VTV has a market cap of 245B. Regarding current trading prices, BCAT is priced at $16.12, while VTV trades at $219.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VTV's P/E ratio is 21.68. In terms of profitability, BCAT's ROE is +0.13%, compared to VTV's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VTV. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTV's competition here
BCAT vs C-PN Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, C-PN has a market cap of 240B. Regarding current trading prices, BCAT is priced at $16.12, while C-PN trades at $28.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas C-PN's P/E ratio is 91.51. In terms of profitability, BCAT's ROE is +0.13%, compared to C-PN's ROE of +0.08%. Regarding short-term risk, BCAT is more volatile compared to C-PN. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check C-PN's competition here
BCAT vs PONPX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, PONPX has a market cap of 227.4B. Regarding current trading prices, BCAT is priced at $16.12, while PONPX trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas PONPX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to PONPX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to PONPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check PONPX's competition here
BCAT vs PIMIX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, PIMIX has a market cap of 227.4B. Regarding current trading prices, BCAT is priced at $16.12, while PIMIX trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas PIMIX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to PIMIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to PIMIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check PIMIX's competition here
BCAT vs VO Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VO has a market cap of 219.8B. Regarding current trading prices, BCAT is priced at $16.12, while VO trades at $80.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VO's P/E ratio is 23.96. In terms of profitability, BCAT's ROE is +0.13%, compared to VO's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VO. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VO's competition here
BCAT vs VMCIX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VMCIX has a market cap of 218.5B. Regarding current trading prices, BCAT is priced at $16.12, while VMCIX trades at $88.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VMCIX's P/E ratio is 23.93. In terms of profitability, BCAT's ROE is +0.13%, compared to VMCIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VMCIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VMCIX's competition here
BCAT vs VIMAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VIMAX has a market cap of 218.5B. Regarding current trading prices, BCAT is priced at $16.12, while VIMAX trades at $400.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VIMAX's P/E ratio is 23.93. In terms of profitability, BCAT's ROE is +0.13%, compared to VIMAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VIMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VIMAX's competition here
BCAT vs VMCPX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VMCPX has a market cap of 218.5B. Regarding current trading prices, BCAT is priced at $16.12, while VMCPX trades at $436.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VMCPX's P/E ratio is 23.93. In terms of profitability, BCAT's ROE is +0.13%, compared to VMCPX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VMCPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VMCPX's competition here
BCAT vs ODIDX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, ODIDX has a market cap of 211.3B. Regarding current trading prices, BCAT is priced at $16.12, while ODIDX trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas ODIDX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to ODIDX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to ODIDX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check ODIDX's competition here
BCAT vs FFICX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FFICX has a market cap of 187.9B. Regarding current trading prices, BCAT is priced at $16.12, while FFICX trades at $68.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FFICX's P/E ratio is 28.51. In terms of profitability, BCAT's ROE is +0.13%, compared to FFICX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FFICX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FFICX's competition here
BCAT vs AICCX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AICCX has a market cap of 187.9B. Regarding current trading prices, BCAT is priced at $16.12, while AICCX trades at $67.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AICCX's P/E ratio is 28.50. In terms of profitability, BCAT's ROE is +0.13%, compared to AICCX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AICCX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AICCX's competition here
BCAT vs AICFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AICFX has a market cap of 187.4B. Regarding current trading prices, BCAT is priced at $16.12, while AICFX trades at $68.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AICFX's P/E ratio is 28.50. In terms of profitability, BCAT's ROE is +0.13%, compared to AICFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AICFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AICFX's competition here
BCAT vs RICAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RICAX has a market cap of 187.3B. Regarding current trading prices, BCAT is priced at $16.12, while RICAX trades at $67.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RICAX's P/E ratio is 28.50. In terms of profitability, BCAT's ROE is +0.13%, compared to RICAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RICAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RICAX's competition here
BCAT vs RICBX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RICBX has a market cap of 187.3B. Regarding current trading prices, BCAT is priced at $16.12, while RICBX trades at $67.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RICBX's P/E ratio is 28.50. In terms of profitability, BCAT's ROE is +0.13%, compared to RICBX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RICBX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RICBX's competition here
BCAT vs CICAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, CICAX has a market cap of 186.4B. Regarding current trading prices, BCAT is priced at $16.12, while CICAX trades at $68.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas CICAX's P/E ratio is 28.51. In terms of profitability, BCAT's ROE is +0.13%, compared to CICAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CICAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CICAX's competition here
BCAT vs AIVSX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AIVSX has a market cap of 186.4B. Regarding current trading prices, BCAT is priced at $16.12, while AIVSX trades at $68.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AIVSX's P/E ratio is 28.51. In terms of profitability, BCAT's ROE is +0.13%, compared to AIVSX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AIVSX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AIVSX's competition here
BCAT vs FINFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FINFX has a market cap of 184.2B. Regarding current trading prices, BCAT is priced at $16.12, while FINFX trades at $102.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FINFX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to FINFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FINFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FINFX's competition here
BCAT vs CFNAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, CFNAX has a market cap of 184.2B. Regarding current trading prices, BCAT is priced at $16.12, while CFNAX trades at $102.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas CFNAX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to CFNAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CFNAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CFNAX's competition here
BCAT vs RFNCX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RFNCX has a market cap of 183.7B. Regarding current trading prices, BCAT is priced at $16.12, while RFNCX trades at $102.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RFNCX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to RFNCX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RFNCX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RFNCX's competition here
BCAT vs VB Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VB has a market cap of 183.6B. Regarding current trading prices, BCAT is priced at $16.12, while VB trades at $298.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VB's P/E ratio is 21.80. In terms of profitability, BCAT's ROE is +0.13%, compared to VB's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VB. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VB's competition here
BCAT vs AFIFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AFIFX has a market cap of 182.6B. Regarding current trading prices, BCAT is priced at $16.12, while AFIFX trades at $102.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AFIFX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to AFIFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AFIFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AFIFX's competition here
BCAT vs FUNFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FUNFX has a market cap of 182.6B. Regarding current trading prices, BCAT is priced at $16.12, while FUNFX trades at $102.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FUNFX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to FUNFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FUNFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FUNFX's competition here
BCAT vs ANCFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, ANCFX has a market cap of 182.6B. Regarding current trading prices, BCAT is priced at $16.12, while ANCFX trades at $102.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas ANCFX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to ANCFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to ANCFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check ANCFX's competition here
BCAT vs FCNTX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FCNTX has a market cap of 181.2B. Regarding current trading prices, BCAT is priced at $16.12, while FCNTX trades at $26.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FCNTX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FCNTX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FCNTX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FCNTX's competition here
BCAT vs FCNKX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FCNKX has a market cap of 181.2B. Regarding current trading prices, BCAT is priced at $16.12, while FCNKX trades at $26.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FCNKX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FCNKX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FCNKX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FCNKX's competition here
BCAT vs VSMAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VSMAX has a market cap of 180.9B. Regarding current trading prices, BCAT is priced at $16.12, while VSMAX trades at $143.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VSMAX's P/E ratio is 21.84. In terms of profitability, BCAT's ROE is +0.13%, compared to VSMAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VSMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VSMAX's competition here
BCAT vs VSCIX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VSCIX has a market cap of 180.9B. Regarding current trading prices, BCAT is priced at $16.12, while VSCIX trades at $143.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VSCIX's P/E ratio is 21.84. In terms of profitability, BCAT's ROE is +0.13%, compared to VSCIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VSCIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VSCIX's competition here
BCAT vs RNPCX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RNPCX has a market cap of 173B. Regarding current trading prices, BCAT is priced at $16.12, while RNPCX trades at $72.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RNPCX's P/E ratio is 27.18. In terms of profitability, BCAT's ROE is +0.13%, compared to RNPCX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RNPCX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RNPCX's competition here
BCAT vs FNPFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FNPFX has a market cap of 172.1B. Regarding current trading prices, BCAT is priced at $16.12, while FNPFX trades at $75.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FNPFX's P/E ratio is 27.23. In terms of profitability, BCAT's ROE is +0.13%, compared to FNPFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FNPFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FNPFX's competition here
BCAT vs NPFFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, NPFFX has a market cap of 171.5B. Regarding current trading prices, BCAT is priced at $16.12, while NPFFX trades at $74.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas NPFFX's P/E ratio is 27.21. In terms of profitability, BCAT's ROE is +0.13%, compared to NPFFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to NPFFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check NPFFX's competition here
BCAT vs ANWPX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, ANWPX has a market cap of 171.5B. Regarding current trading prices, BCAT is priced at $16.12, while ANWPX trades at $75.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas ANWPX's P/E ratio is 27.21. In terms of profitability, BCAT's ROE is +0.13%, compared to ANWPX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to ANWPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check ANWPX's competition here
BCAT vs RNPGX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RNPGX has a market cap of 171.5B. Regarding current trading prices, BCAT is priced at $16.12, while RNPGX trades at $75.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RNPGX's P/E ratio is 27.23. In terms of profitability, BCAT's ROE is +0.13%, compared to RNPGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RNPGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RNPGX's competition here
BCAT vs VEMAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VEMAX has a market cap of 161.1B. Regarding current trading prices, BCAT is priced at $16.12, while VEMAX trades at $49.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VEMAX's P/E ratio is 16.73. In terms of profitability, BCAT's ROE is +0.13%, compared to VEMAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VEMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VEMAX's competition here
BCAT vs VEMRX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VEMRX has a market cap of 161.1B. Regarding current trading prices, BCAT is priced at $16.12, while VEMRX trades at $124.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VEMRX's P/E ratio is 16.73. In terms of profitability, BCAT's ROE is +0.13%, compared to VEMRX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VEMRX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VEMRX's competition here
BCAT vs WGIFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, WGIFX has a market cap of 160.6B. Regarding current trading prices, BCAT is priced at $16.12, while WGIFX trades at $81.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas WGIFX's P/E ratio is 25.09. In terms of profitability, BCAT's ROE is +0.13%, compared to WGIFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to WGIFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check WGIFX's competition here
BCAT vs BLK Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, BLK has a market cap of 160.6B. Regarding current trading prices, BCAT is priced at $16.12, while BLK trades at $1,036.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas BLK's P/E ratio is 21.02. In terms of profitability, BCAT's ROE is +0.13%, compared to BLK's ROE of +0.12%. Regarding short-term risk, BCAT is less volatile compared to BLK. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check BLK's competition here
BCAT vs FPMAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FPMAX has a market cap of 156.6B. Regarding current trading prices, BCAT is priced at $16.12, while FPMAX trades at $10.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FPMAX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FPMAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FPMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FPMAX's competition here
BCAT vs AWSHX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AWSHX has a market cap of 151B. Regarding current trading prices, BCAT is priced at $16.12, while AWSHX trades at $67.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AWSHX's P/E ratio is 26.04. In terms of profitability, BCAT's ROE is +0.13%, compared to AWSHX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AWSHX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AWSHX's competition here
BCAT vs RWMFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RWMFX has a market cap of 150.9B. Regarding current trading prices, BCAT is priced at $16.12, while RWMFX trades at $67.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RWMFX's P/E ratio is 26.04. In terms of profitability, BCAT's ROE is +0.13%, compared to RWMFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RWMFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RWMFX's competition here
BCAT vs FWMIX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FWMIX has a market cap of 150.9B. Regarding current trading prices, BCAT is priced at $16.12, while FWMIX trades at $67.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FWMIX's P/E ratio is 26.04. In terms of profitability, BCAT's ROE is +0.13%, compared to FWMIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FWMIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FWMIX's competition here
BCAT vs CWMAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, CWMAX has a market cap of 150.4B. Regarding current trading prices, BCAT is priced at $16.12, while CWMAX trades at $66.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas CWMAX's P/E ratio is 26.04. In terms of profitability, BCAT's ROE is +0.13%, compared to CWMAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CWMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CWMAX's competition here
BCAT vs WSHFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, WSHFX has a market cap of 150.1B. Regarding current trading prices, BCAT is priced at $16.12, while WSHFX trades at $66.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas WSHFX's P/E ratio is 26.04. In terms of profitability, BCAT's ROE is +0.13%, compared to WSHFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to WSHFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check WSHFX's competition here
BCAT vs BX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, BX has a market cap of 147.8B. Regarding current trading prices, BCAT is priced at $16.12, while BX trades at $123.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas BX's P/E ratio is 21.07. In terms of profitability, BCAT's ROE is +0.13%, compared to BX's ROE of +0.36%. Regarding short-term risk, BCAT is less volatile compared to BX. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check BX's competition here
BCAT vs WSHCX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, WSHCX has a market cap of 147.7B. Regarding current trading prices, BCAT is priced at $16.12, while WSHCX trades at $65.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas WSHCX's P/E ratio is 26.01. In terms of profitability, BCAT's ROE is +0.13%, compared to WSHCX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to WSHCX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check WSHCX's competition here
BCAT vs RWMBX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RWMBX has a market cap of 147.2B. Regarding current trading prices, BCAT is priced at $16.12, while RWMBX trades at $65.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RWMBX's P/E ratio is 26.01. In terms of profitability, BCAT's ROE is +0.13%, compared to RWMBX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RWMBX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RWMBX's competition here
BCAT vs FIFAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FIFAX has a market cap of 146.9B. Regarding current trading prices, BCAT is priced at $16.12, while FIFAX trades at $27.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FIFAX's P/E ratio is 19.39. In terms of profitability, BCAT's ROE is +0.13%, compared to FIFAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FIFAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FIFAX's competition here
BCAT vs SWPPX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, SWPPX has a market cap of 145.2B. Regarding current trading prices, BCAT is priced at $16.12, while SWPPX trades at $19.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas SWPPX's P/E ratio is 27.00. In terms of profitability, BCAT's ROE is +0.13%, compared to SWPPX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to SWPPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check SWPPX's competition here
BCAT vs AEGFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AEGFX has a market cap of 144.3B. Regarding current trading prices, BCAT is priced at $16.12, while AEGFX trades at $62.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AEGFX's P/E ratio is 19.23. In terms of profitability, BCAT's ROE is +0.13%, compared to AEGFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AEGFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AEGFX's competition here
BCAT vs RERHX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RERHX has a market cap of 144.3B. Regarding current trading prices, BCAT is priced at $16.12, while RERHX trades at $62.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RERHX's P/E ratio is 19.24. In terms of profitability, BCAT's ROE is +0.13%, compared to RERHX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RERHX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RERHX's competition here
BCAT vs RERGX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, RERGX has a market cap of 143.5B. Regarding current trading prices, BCAT is priced at $16.12, while RERGX trades at $63.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas RERGX's P/E ratio is 19.26. In terms of profitability, BCAT's ROE is +0.13%, compared to RERGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RERGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RERGX's competition here
BCAT vs AEPFX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AEPFX has a market cap of 143.5B. Regarding current trading prices, BCAT is priced at $16.12, while AEPFX trades at $63.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AEPFX's P/E ratio is 19.25. In terms of profitability, BCAT's ROE is +0.13%, compared to AEPFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AEPFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AEPFX's competition here
BCAT vs AEPGX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AEPGX has a market cap of 143.2B. Regarding current trading prices, BCAT is priced at $16.12, while AEPGX trades at $63.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AEPGX's P/E ratio is 19.24. In terms of profitability, BCAT's ROE is +0.13%, compared to AEPGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AEPGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AEPGX's competition here
BCAT vs VITAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, VITAX has a market cap of 138.9B. Regarding current trading prices, BCAT is priced at $16.12, while VITAX trades at $482.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas VITAX's P/E ratio is 35.37. In terms of profitability, BCAT's ROE is +0.13%, compared to VITAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VITAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VITAX's competition here
BCAT vs FSKAX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, FSKAX has a market cap of 138.4B. Regarding current trading prices, BCAT is priced at $16.12, while FSKAX trades at $208.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas FSKAX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FSKAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FSKAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FSKAX's competition here
BCAT vs NAESX Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, NAESX has a market cap of 137.9B. Regarding current trading prices, BCAT is priced at $16.12, while NAESX trades at $143.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas NAESX's P/E ratio is 21.85. In terms of profitability, BCAT's ROE is +0.13%, compared to NAESX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to NAESX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check NAESX's competition here
BCAT vs AGG Comparison July 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.7B. In comparison, AGG has a market cap of 137.6B. Regarding current trading prices, BCAT is priced at $16.12, while AGG trades at $98.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.60, whereas AGG's P/E ratio is 253.12. In terms of profitability, BCAT's ROE is +0.13%, compared to AGG's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to AGG. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AGG's competition here